Comorbidity of atrial fibrillation and heart failure (Q38666884)

5 September 2017

title

Comorbidity of atrial fibrillation and heart failure (English)

1 reference

5 September 2017

0 references

0 references

1 reference

Liang-Han Ling

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26658575%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Richard J Schilling

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26658575%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Ross J Hunter

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26658575%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

language of work or name

English

0 references

publication date

10 December 2015

1 reference

Nature Reviews Cardiology

5 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26658575%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26658575%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26658575%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

page(s)

131-147

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26658575%20AND%20SRC:MED&resulttype=core&format=json

Cardiovascular Medicine at the Turn of the Millennium: Triumphs, Concerns, and Opportunities

9 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Atrial fibrillation and congestive heart failure: specific considerations at the intersection of two common and important cardiac disease sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Epidemiology of Heart Failure in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Epidemiology of Heart Failure in Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Heart Failure in Rural Communities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Prevention of heart failure: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Int

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

The Epidemiologic Transition: A Theory of the Epidemiology of Population Change

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Estimation of total incremental health care costs in patients with atrial fibrillation in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

The annual global economic burden of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Atrial fibrillation--the growing epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Predisposing factors and incidence of newly diagnosed atrial fibrillation in an urban African community: insights from the Heart of Soweto Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Incidence of and Risk Factors for Atrial Fibrillation in Older Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Long-Term Trends in the Incidence of and Survival with Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Congestive heart failure in the community: trends in incidence and survival in a 10-year period

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

The epidemiology of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Clinical epidemiology of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Incidence and aetiology of heart failure; a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Incidence and outcome of persons with a clinical diagnosis of heart failure in a general practice population of 696,884 in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Epidemiology of heart failure in a community-based study of subjects aged > or = 57 years: incidence and long-term survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

The burden and costs of chronic diseases in low-income and middle-income countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Emerging Epidemic of Cardiovascular Disease in Developing Countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Gender differences in clinical characteristics and outcome of acute heart failure in sub-Saharan Africa: results of the THESUS-HF study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Variations in cause and management of atrial fibrillation in a prospective registry of 15,400 emergency department patients in 46 countries: the RE-LY Atrial Fibrillation Registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

The causes, treatment, and outcome of acute heart failure in 1006 Africans from 9 countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Heart failure: a global disease requiring a global response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Obesity and the Risk of New-Onset Atrial Fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Pathophysiology of concomitant atrial fibrillation and heart failure: implications for management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Atrial fibrillation and ventricular dysfunction: a vicious electromechanical cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). The Dep

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Dabigatran, Rivaroxaban, or Apixaban versus Warfarin in Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Subgroups

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Incidence and mortality risk of congestive heart failure in atrial fibrillation patients: a community-based study over two decades

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Impact of atrial fibrillation on the risk of death: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Role of intracellular calcium handling in force-interval relationships of human ventricular myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Effect of atrial fibrillation and an irregular ventricular response on sympathetic nerve activity in human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

The synergism between atrial fibrillation and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Comparison of plasma neurohormones in congestive heart failure patients with atrial fibrillation versus patients with sinus rhythm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Catheter ablation for atrial fibrillation in congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

The clinical, electrocardiographic and echocardiographic characteristics and long-term outcome of patients with tachycardia-induced cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Prospective study of left ventricular function after radiofrequency ablation of atrioventricular junction in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Improvement in left ventricular systolic function after successful radiofrequency His bundle ablation for drug refractory, chronic atrial fibrillation and recurrent atrial flutter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Alterations in myocyte shape and basement membrane attachment with tachycardia-induced heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Calcium cycling in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Abnormalities of calcium cycling in the hypertrophied and failing heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Mechanism of altered patterns of left ventricular filling during the development of congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Alterations in left ventricular diastolic function in conscious dogs with pacing-induced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Evaluation of indices of left ventricular contractility and relaxation in evolving canine experimental heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Dysfunction of the beta- and alpha-adrenergic systems in a model of congestive heart failure. The pacing-overdrive dog.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Beta-adrenergic receptor-G protein-adenylate cyclase complex in experimental canine congestive heart failure produced by rapid ventricular pacing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Abnormalities in intracellular calcium regulation and contractile function in myocardium from dogs with pacing-induced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Cellular and molecular alterations in the beta adrenergic system with cardiomyopathy induced by tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

The cellular basis for the blunted response to beta-adrenergic stimulation in supraventricular tachycardia-induced cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Continuous measurement of the pressure-volume relationship in experimental heart failure produced by rapid ventricular pacing in conscious dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Recovery from prolonged abnormalities of canine myocardium salvaged from ischemic necrosis by coronary reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Cardiac resynchronization therapy in patients with atrial fibrillation: the CERTIFY study (Cardiac Resynchronization Therapy in Atrial Fibrillation Patients Multinational Registry).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Diffuse ventricular fibrosis is a late outcome of tachycardia-mediated cardiomyopathy after successful ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Temporal relationship and prognostic significance of atrial fibrillation in heart failure patients with preserved ejection fraction: a community-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

The prognostic significance of atrial fibrillation in heart failure with a preserved and reduced left ventricular function: insights from a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Probucol attenuates left ventricular dysfunction and remodeling in tachycardia-induced heart failure: roles of oxidative stress and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Antioxidant vitamins attenuate oxidative stress and cardiac dysfunction in tachycardia-induced cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Chronic heart failure and the substrate for atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Molecular mechanisms underlying ionic remodeling in a dog model of atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Calcium-handling abnormalities underlying atrial arrhythmogenesis and contractile dysfunction in dogs with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Prevention of atrial fibrillation by Renin-Angiotensin system inhibition a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Enalapril prevents perpetuation of atrial fibrillation by suppressing atrial fibrosis and over-expression of connexin43 in a canine model of atrial pacing-induced left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Epidemiology and natural history of atrial fibrillation: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Association between atrial fibrillation and appropriate implantable cardioverter defibrillator therapy: results from a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Prognostic importance of atrial fibrillation in implantable cardioverter-defibrillator patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Previously known and newly diagnosed atrial fibrillation: a major risk indicator after a myocardial infarction complicated by heart failure or left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Rhythm control versus rate control for atrial fibrillation and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Incident atrial fibrillation and mortality in older adults with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Atrial fibrillation and mortality in heart failure: a community study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Implantable cardioverter-defibrillator therapy and risk of congestive heart failure or death in MADIT II patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Atrial fibrillation and heart failure: treatment considerations for a dual epidemic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Increased risk of sudden and non-sudden cardiovascular death in patients with atrial fibrillation/flutter following acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Left ventricular systolic dysfunction, heart failure, and the risk of stroke and systemic embolism in patients with atrial fibrillation: insights from the ARISTOTLE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Dabigatran versus warfarin in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Apixaban versus warfarin in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Edoxaban versus warfarin in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

A comparison of rate control and rhythm control in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Functional status in rate- versus rhythm-control strategies for atrial fibrillation: results of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Functional Status Substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Randomized trial of rhythm or rate control in atrial fibrillation: the Pharmacological Intervention in Atrial Fibrillation Trial (PIAF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Connexin 43 expression and distribution in compensated and decompensated cardiac hypertrophy in patients with aortic stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (diamond) substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Beta-blockers and outcome in heart failure and atrial fibrillation: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Death and digoxin: stop me if you've heard this one before

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Digoxin and mortality in atrial fibrillation: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Digoxin in atrial fibrillation: report from the Stockholm Cohort study of Atrial Fibrillation (SCAF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Increased mortality associated with digoxin in contemporary patients with atrial fibrillation: findings from the TREAT-AF study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Atrial fibrillation in heart failure: drug therapies for rate and rhythm control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Lenient vs. strict rate control in patients with atrial fibrillation and heart failure: a post-hoc analysis of the RACE II study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Effect of lenient versus strict rate control on cardiac remodeling in patients with atrial fibrillation data of the RACE II (RAte Control Efficacy in permanent atrial fibrillation II) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Is rhythm-control superior to rate-control in patients with atrial fibrillation and diastolic heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Enhanced sensitivity to drug-induced QT interval lengthening in patients with heart failure due to left ventricular systolic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Impact of rate versus rhythm control on quality of life in patients with persistent atrial fibrillation. Results from a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Review of Contemporary Antiarrhythmic Drug Therapy for Maintenance of Sinus Rhythm in Atrial Fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Amiodarone and the risk of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Effect of dronedarone on cardiovascular events in atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Increased mortality after dronedarone therapy for severe heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Dronedarone in High-Risk Permanent Atrial Fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Interaction between digoxin and dronedarone in the PALLAS trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Catheter ablation and antiarrhythmic drug therapy as first- or second-line therapy in the management of atrial fibrillation: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Rhythm control in heart failure patients with atrial fibrillation: contemporary challenges including the role of ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Complications from catheter ablation of atrial fibrillation: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Complications of catheter ablation of atrial fibrillation: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Catheter ablation of atrial fibrillation in patients with left ventricular systolic dysfunction: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Left ventricular systolic dysfunction by itself does not influence outcome of atrial fibrillation ablation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Pulmonary-vein isolation for atrial fibrillation in patients with heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Catheter ablation of paroxysmal atrial fibrillation improves cardiac function: a prospective study on the impact of atrial fibrillation ablation on left ventricular function assessed by magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Radiofrequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Long-term results of transcatheter atrial fibrillation ablation in patients with impaired left ventricular systolic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Success of ablation for atrial fibrillation in isolated left ventricular diastolic dysfunction: a comparison to systolic dysfunction and normal ventricular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

A randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure (the CAMTAF trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

A randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Catheter ablation for atrial fibrillation in patients with left ventricular systolic dysfunction. A systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

In-hospital complications associated with catheter ablation of atrial fibrillation in the United States between 2000 and 2010: analysis of 93 801 procedures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Subtle post-procedural cognitive dysfunction after atrial fibrillation ablation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Efficacy, safety, and outcomes of catheter ablation of atrial fibrillation in patients with heart failure with preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

The effect of cardiac resynchronization on morbidity and mortality in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Cardiac-resynchronization therapy for the prevention of heart-failure events

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Role of AV nodal ablation in cardiac resynchronization in patients with coexistent atrial fibrillation and heart failure a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Effects of atrioventricular nodal ablation on permanent atrial fibrillation patients with cardiac resynchronization therapy: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Irbesartan in patients with heart failure and preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Combination of isosorbide dinitrate and hydralazine in blacks with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial

21 January 2018

2 references

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

21 January 2018

12 December 2020

Trends in Heart Failure Incidence and Survival in a Community-Based Population

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Recurrence of arrhythmia following short-term oral AMIOdarone after CATheter ablation for atrial fibrillation: a double-blind, randomized, placebo-controlled study (AMIO-CAT trial)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Irregular Rhythm Adversely Influences Calcium Handling in Ventricular Myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Reversal of Left Ventricular Dysfunction Following Ablation of Atrial Fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Electrical Remodeling of the Atria in Congestive Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Cost of care distribution in atrial fibrillation patients: the COCAF study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left V

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Global epidemic of atrial fibrillation including China

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Atrial contribution to ventricular filling in mitral stenosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Left atrial transport function in myocardial infarction. Importance of its booster pump function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Influence of atrial systole on the Frank-Starling relation and the end-diastolic pressure-diameter relation of the left ventricle

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Increased cardiac adrenergic drive precedes generalized sympathetic activation in human heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Cardiorenal and neurohumoral function in a canine model of early left ventricular dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Persistent left ventricular dilatation in tachycardia-induced cardiomyopathy patients after appropriate treatment and normalization of ejection fraction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Clinical characteristics, treatment, and outcome of tachycardia induced cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Tachycardia-mediated cardiomyopathy secondary to focal atrial tachycardia: long-term outcome after catheter ablation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Improvement in left ventricular function by ablation of atrioventricular nodal conduction in selected patients with lone atrial fibrillation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Recovery from heart failure: structural and functional analysis in a canine model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Evaluation of ventricular contractility indexes in the dog with left ventricular dysfunction induced by rapid atrial pacing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Sequential echocardiographic-Doppler assessment of left ventricular remodelling and mitral regurgitation during evolving experimental heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Changes in left ventricular volume, mass, and function during the development and regression of supraventricular tachycardia-induced cardiomyopathy. Disparity between recovery of systolic versus diastolic function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Effect of chronic supraventricular tachycardia on left ventricular function and structure in newborn pigs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Cellular and extracellular remodeling with the development and recovery from tachycardia-induced cardiomyopathy: changes in fibrillar collagen, myocyte adhesion capacity and proteoglycans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

The cellular basis of pacing-induced dilated cardiomyopathy. Myocyte cell loss and myocyte cellular reactive hypertrophy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Rapid ventricular pacing of dogs to heart failure: biochemical and physiological studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Experimental congestive heart failure produced by rapid ventricular pacing in the dog: cardiac effects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

The relationship between altered load and impaired diastolic function in conscious dogs with pacing induced heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

The renin-angiotensin-aldosterone system, antidiuretic hormone and sympathetic nerve activity in an experimental model of congestive heart failure in the dog

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Relation between ventricular and myocyte function with tachycardia-induced cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Left ventricular remodelling and disparate changes in contractility and relaxation during the development of and recovery from experimental heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Myocardial Na+,K+-ATPase in tachycardia induced cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Changes in myocardial blood flow during development of and recovery from tachycardia-induced cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Autocrine control of wound repair by insulin-like growth factor I in cultured endothelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Prolonged depletion of ATP and of the adenine nucleotide pool due to delayed resynthesis of adenine nucleotides following reversible myocardial ischemic injury in dogs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Diffuse ventricular fibrosis in atrial fibrillation: noninvasive evaluation and relationships with aging and systolic dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Diffuse myocardial fibrosis evaluated by post-contrast t1 mapping correlates with left ventricular stiffness

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Dissociation between ionic remodeling and ability to sustain atrial fibrillation during recovery from experimental congestive heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Disorganization of gap junction distribution in dilated atria of patients with chronic atrial fibrillation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Differences in atrial versus ventricular remodeling in dogs with ventricular tachypacing-induced congestive heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Effects of simvastatin on the development of the atrial fibrillation substrate in dogs with congestive heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Left atrial wall stress distribution and its relationship to electrophysiologic remodeling in persistent atrial fibrillation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Prognostic significance of atrial fibrillation in patients at a tertiary medical center referred for heart transplantation because of severe heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Predictors of primary atrial fibrillation and concomitant clinical and hemodynamic changes in patients with chronic heart failure: a prospective study in 344 patients with baseline sinus rhythm

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Atrial fibrillation is under-recognized in chronic heart failure: insights from a heart failure cohort treated with cardiac resynchronization therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Prevalence and prognostic significance of atrial fibrillation in outpatients with heart failure due to left ventricular systolic dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Non-valvular atrial fibrillation patients with none or one additional risk factor of the CHA2DS2-VASc score. A comprehensive net clinical benefit analysis for warfarin, aspirin, or no therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Quality of life in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Prognostic Significance of Resting Heart Rate and Use of β-Blockers in Atrial Fibrillation and Sinus Rhythm in Patients With Heart Failure and Reduced Ejection Fraction: Findings From the Swedish Heart Failure Registry

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

The effect of digoxin on mortality and morbidity in patients with heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Increased mortality among patients taking digoxin--analysis from the AFFIRM study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Outcomes with digoxin in atrial fibrillation: more data, no answers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Maintenance of sinus rhythm and survival in patients with heart failure and atrial fibrillation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Amiodarone, anticoagulation, and clinical events in patients with atrial fibrillation: insights from the ARISTOTLE trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Prevention of implantable-defibrillator shocks by treatment with sotalol. d,l-Sotalol Implantable Cardioverter-Defibrillator Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Ablation vs medical therapy in the setting of symptomatic atrial fibrillation and left ventricular dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Sinus rhythm restores ventricular function in patients with cardiomyopathy and no late gadolinium enhancement on cardiac magnetic resonance imaging who undergo catheter ablation for atrial fibrillation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Radiofrequency catheter ablation of atrial fibrillation: a cause of silent thromboembolism? Magnetic resonance imaging assessment of cerebral thromboembolism in patients undergoing ablation of atrial fibrillation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Catheter ablation versus standard conventional treatment in patients with left ventricular dysfunction and atrial fibrillation (CASTLE-AF) - study design

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Biventricular pacing for atrioventricular block and systolic dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.191

Management of atrial fibrillation in the setting of heart failure

31 March 2020

1 reference

12 December 2020

Early recovery from heart failure: insights into the pathogenesis of experimental chronic pacing-induced heart failure

1 reference

12 December 2020

Collagen remodeling and changes in LV function during development and recovery from supraventricular tachycardia

1 reference

12 December 2020

Alterations in myocardial contractility in conscious dogs with dilated cardiomyopathy

1 reference

12 December 2020

Efficacy of amiodarone in patients with atrial fibrillation with and without left ventricular dysfunction: a pooled analysis of AFFIRM and AF-CHF trials

1 reference

12 December 2020

Impaired regional subendocardial coronary flow reserve in conscious dogs with pacing-induced heart failure

1 reference

12 December 2020

Assessing the burden of mortality from cardiovascular diseases.

1 reference

12 December 2020

Effects of spironolactone on electrical and structural remodeling of atrium in congestive heart failure dogs

1 reference

12 December 2020

The pig as a model of tachycardia and dilated cardiomyopathy.

1 reference

12 December 2020

Chronic supraventricular tachycardia causes ventricular dysfunction and subendocardial injury in swine

1 reference

12 December 2020

Left ventricular myocardial blood flow, metabolism, and effects of treatment with enalapril: further insights into the mechanisms of canine experimental pacing-induced heart failure

1 reference

12 December 2020

1 reference

12 December 2020

LV and myocyte structure and function after early recovery from tachycardia-induced cardiomyopathy

1 reference

12 December 2020

The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V-HeFT Studies. The V-HeFT VA Cooperative Studies Group

1 reference

12 December 2020

Left ventricular dysfunction and dilatation resulting from chronic supraventricular tachycardia

1 reference

12 December 2020

Exhaustion of Frank-Starling mechanism in conscious dogs with heart failure.

1 reference

12 December 2020

Ablation of atrial fibrillation in patients with heart failure: reversal of atrial and ventricular remodelling

1 reference

12 December 2020

Ventricular remodeling during development and recovery from modified tachycardia-induced cardiomyopathy model

1 reference

12 December 2020

Effects of chronic supraventricular pacing tachycardia on relaxation rate in isolated cardiac muscle cells

1 reference

12 December 2020

Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials

1 reference

12 December 2020

Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study

1 reference

12 December 2020

10.1038/NRCARDIO.2015.191

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26658575%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

9 June 2020

1033175940

0 references

Fatcat ID

release_452qjozwivcp3doqllkslopqme

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/452qjozwivcp3doqllkslopqme

24 November 2022

mapped directly with Wikidata item

1 reference